(Korean) 이노엔, 보로노이서 '선택적 RET 저해제' 도입…항암신약 개발 - 한국경제 BIO Insight anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/02/15 JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field - mk.co.krOn December 2, JW Pharmaceutical inked a deal with Korean biotech startup Voronoi to develop next-generation innovative new drugs. It plans to develop a next-generation innovative new drug with global competitiveness by combining JW Pharmaceutical's small molecule anticancer drug candidate of targeting STAT3 with Voronoi's protein decomposition technology 'Protein Degrader(PROTAC; Proteolysis-targeting chimera)'. 기사 전문보기 2021/01/27 (Korean) 보로노이, 美제약사에 폐암 치료제 7200억 기술수출 anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/01/27 Dana-Farber Cancer Institute visits VORONOI…"Strengthening partnerships by strengthening joint research, etc." anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2019/12/30 (Korean) 보로노이, 항암 분야 세계 석학 자문위원으로 위촉 - IT조선 anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2019/12/30 2019 VORONOI Symposium…Domestic and foreign drug development experts participated - hankyung.com anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline 2019 VORONOI Symposium…Domestic and foreign drug development experts participated - hankyung.comAt the symposium held at the Westin Chosun Hotel in Seoul on May 14th, under the slogan of 'from basics to clinical', domestic and foreign drug development experts participated and shared the latest trends in academia. 기사 전문보기 2019/12/30